Aetna Inc. (AET) Shares Sold by FTB Advisors Inc.
FTB Advisors Inc. cut its position in shares of Aetna Inc. (NYSE:AET) by 6.1% during the second quarter, Holdings Channel reports. The firm owned 874 shares of the company’s stock after selling 57 shares during the period. FTB Advisors Inc.’s holdings in Aetna were worth $107,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of AET. Renaissance Technologies LLC boosted its stake in Aetna by 111.5% in the first quarter. Renaissance Technologies LLC now owns 412,190 shares of the company’s stock worth $46,310,000 after buying an additional 217,300 shares during the period. PGGM Investments boosted its stake in Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock worth $97,080,000 after buying an additional 280,978 shares during the period. Bridger Management LLC acquired a new stake in Aetna during the first quarter worth $62,926,000. Panagora Asset Management Inc. boosted its stake in Aetna by 10.2% in the first quarter. Panagora Asset Management Inc. now owns 1,212,479 shares of the company’s stock worth $136,222,000 after buying an additional 112,572 shares during the period. Finally, Nisa Investment Advisors LLC boosted its stake in Aetna by 4.1% in the second quarter. Nisa Investment Advisors LLC now owns 145,191 shares of the company’s stock worth $17,732,000 after buying an additional 5,750 shares during the period. Institutional investors and hedge funds own 91.94% of the company’s stock.
Aetna Inc. (NYSE:AET) traded down 0.33% during trading on Wednesday, reaching $111.06. The company’s stock had a trading volume of 2,505,430 shares. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $123.57. The company has a market cap of $38.96 billion, a PE ratio of 16.27 and a beta of 0.54. The stock has a 50-day moving average price of $114.55 and a 200 day moving average price of $115.72.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.12 by $0.09. The firm had revenue of $15.95 billion for the quarter, compared to analyst estimates of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The business’s revenue was up 4.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.05 earnings per share. On average, analysts expect that Aetna Inc. will post $8.05 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be paid a $0.25 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.00 annualized dividend and a dividend yield of 0.90%. Aetna’s payout ratio is presently 14.73%.
AET has been the topic of a number of research analyst reports. Credit Suisse Group AG restated a “hold” rating and issued a $120.00 price target on shares of Aetna in a research note on Tuesday, August 30th. Leerink Swann reaffirmed an “outperform” rating on shares of Aetna in a report on Wednesday, August 24th. Evercore ISI began coverage on Aetna in a report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price objective on the stock. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $128.00 price objective on the stock in a report on Tuesday, October 4th. Finally, Jefferies Group reaffirmed a “hold” rating on shares of Aetna in a report on Tuesday, August 23rd. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $132.43.
In other Aetna news, insider Shawn M. Guertin sold 45,328 shares of the business’s stock in a transaction on Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the sale, the insider now directly owns 44,883 shares in the company, valued at $5,395,385.43. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jeffrey E. Garten sold 7,100 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.